The objectives of this proposal are to characterize the physiological and pathological effects of vascular cells on activation of coagulation. I have determined that intrabovine aortic endothelial (ABAE) cells lack the ability to initiate coagulation by either the intrinsic or extrinsic pathway. However, ABAE cells, but not non-vascular cells (fibroblasts, fetal lung cells), catalyze activation of prothrombin by Factor X and calcium. Although exogenous Factor V has no effect on this reaction, anti-FactoraV IgG inhibits prothrombin activation. Factor V activity was detected in ABAE cells grown in serum-free media for 3 months, indicating that these cells probably synthesize Factor V. Comparison of prothrombin activation by aortic endothelial cells and platelets suggests that endothelial cells generate more thrombin than do an equivalent number of thrombin-activated platelets. These data suggest that endothelial cells may be an important catalyst in hemostasis. I propose: 1) to further characterize the role of aortic endothelium in prothrombin activation by studying the binding of 125I-Factor Xa to these cells as well as determine how Factor V is activated in this reaction; 2) to determine whether cultured vascular cells or vascular cells in situ catalyze the activation of (a) Factor IX by Factor VII, and b) the activation of Factor X by Factors IXa and VIIIa. If vascular cells catalyze either of these reactions, I will characterize them. In addition, I plan to develop experimental models of vascular injury that permit study of pathological interactions between vascular cells and the coagulation system, including in vitro models of cell unjury induced by lipopolysaccharide, low density lipoprotein and activated granulocytes. The methods to be used for this research include purification of coagulation factors involved in these reactions, establishment of vascular and nonvascular cells in culture; development of methods to study vascular cells in situ; and electrophoretic and/or functional assays to measure activation of coagulation factors by vascular cells. These studies may idenfity previously uncharacterized normal and pathological interactions between vascular cells and the coagulation system. Additionally, they may provide information which would enhance our understanding of the mechanisms involved in thrombosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033005-02
Application #
3344608
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1984-01-01
Project End
1986-12-31
Budget Start
1985-01-01
Budget End
1985-12-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
J. David Gladstone Institutes
Department
Type
DUNS #
047120084
City
San Francisco
State
CA
Country
United States
Zip Code
94158
Furlong, C E; Li, W F; Brophy, V H et al. (2000) The PON1 gene and detoxication. Neurotoxicology 21:581-7
Furlong, C E; Li, W F; Richter, R J et al. (2000) Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Neurotoxicology 21:91-100
Rodgers, G M; Conn, M T (1990) Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75:895-901
Rodgers, G M; Taylor, R N; Roberts, J M (1988) Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 159:908-14
Rodgers, G M; Kane, W H; Pitas, R E (1988) Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation. J Clin Invest 81:1911-9
Rodgers, G M (1988) Vascular smooth muscle cells synthesize, secrete and express coagulation factor V. Biochim Biophys Acta 968:17-23
Rodgers, G M (1988) Hemostatic properties of normal and perturbed vascular cells. FASEB J 2:116-23
Rodgers, G M; Cong, J Y; Goll, D E et al. (1987) Activation of coagulation factor V by calcium-dependent proteinase. Biochim Biophys Acta 929:263-70
Rodgers, G M; Shuman, M A (1987) Enhancement of prothrombin activation on platelets by endothelial cells and mechanism of activation of factor V. Thromb Res 45:145-52
Rodgers, G M; Kane, W H (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909-16